International Brain Research Foundation Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT02696512
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

International Brain Research Foundation